The valuable world of Real World Evidence
December 8, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical trials, data, martin goldman, real world evidence, transparency
What do you believe? Are you a doubting Thomas, always wanting to have the pragmatic proof personally presented to you, …
ABPI appoints first manufacturing director
December 8, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, James Christie
The Association of the British Pharmaceutical Industry (ABPI) has appointed James Christie to the newly-created position of project director for …
Bayer files haemophilia drug in EU
December 5, 2014Sales and Marketing BAY 81-8973, Bayer, Biogen IDEC, EMA, elocta, haemophilia a, kogenate
Bayer has submitted a marketing authorisation application to the EMA for its haemophilia A therapy BAY 81-8973. The German firm’s …
GSK cancels sale of established products
December 5, 2014Medical Communications, Sales and Marketing FDA, GSK, Paxil, Seroxat, Zantac, bribery, cuts, imitrex
GlaxoSmithKline has decided not to sell off several of its ageing brands in the face of continuing business problems. The …
Merck sells manufacturing facility to Sanofi
December 5, 2014Manufacturing and Production, Sales and Marketing Merck, Merial, Puerto Rico, Sanofi, manufacturing
Sanofi’s animal health unit Merial is acquiring Merck’s manufacturing facility in Barceloneta, Puerto Rico. The proposed transaction requires the nod …
Ranbaxy launches J&J biosimilar in India
December 5, 2014Manufacturing and Production, Sales and Marketing CHMP, FDA, India, J&J, JJ, Ranbaxy, Remicade, nlem, nppa
Ranbaxy has launched the first biosimilar of Johnson & Johnson’s Remicade (infliximab) in India, marking the firm’s entry into monoclonal …
Speedy FDA nod for Amgen leukaemia drug
December 5, 2014Research and Development, Sales and Marketing B-cell lymphoblasts, FDA, Kyprolis, blinatumomab, blincyto, leukaemia
The FDA has approved Amgen’s Blincyto (blinatumomab) to treat patients with Philadelphia chromosome-negative precursor B-cell acute lymphoblastic leukaemia (B-cell ALL). …
IDEA Pharma appoints two vice presidents
December 5, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 90px, IDEA Pharma, kelly, weston
IDEA Pharma has hired both Samantha Weston and Paul Kelly as vice presidents in business development to boost the company’s …
Actavis to axe 200 jobs
December 4, 2014Medical Communications, Sales and Marketing Actavis, Allergan, Forest, GSK, Warner Chilcott, corona, stevenage
Actavis is set to cut 200 jobs in the US just weeks after buying Allergan for $66 billion. The lay-offs …
Government seeks stakeholder consultation over NICE
December 4, 2014Sales and Marketing ABPI, NHS, NICE, UK, emms, freeman, government, ndpb
NICE stakeholders are being asked for their views on its future as part of the government’s ongoing review into the …
Astellas ‘app challenge’ aims to inspire future talent
December 4, 2014Medical Communications, Sales and Marketing Astellas, CDF, CRUK, Ken Jones, app, my jar, stem
Last week Astellas announced the winner of its Science, Technology, Engineering, and Mathematics (STEM) skills Innovation Challenge competition at an …
Merck Ebola vaccine shows promise
December 4, 2014Research and Development, Sales and Marketing Ebola, Merck, VSV-ZEBOV, WHO, hug, newlink genetics
Merck and NewLink Genetics’ experimental Ebola vaccine has shown no major side effects in its first trial according to the …
ABPI director jumps ship to EFPIA
December 4, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, EFPIA, Whitehead, andrew powrie-smith, andrew-powrie-smith
ABPI director Andrew Powrie-Smith is leaving the body to join The European Federation of Pharmaceutical Industries and Associations (EFPIA) as …
GSK confirms hundreds of US job cuts
December 3, 2014Medical Communications, Research and Development, Sales and Marketing Advair, GSK, Parexel, RTP, anoro, breo, job cuts, respiratory
GlaxoSmithKline has finally confirmed the rumours that it is cutting hundreds of US jobs as the UK firm struggles to …
UK budget sees R&D tax credits rise
December 3, 2014Sales and Marketing Budget, Cameron, George Osborne, NHS, Whitehead, life sciences
Chancellor George Osborne has delivered the government’s 2014 Autumn Statement to the Commons which includes news of an increase in …
Evotec and Sanofi enter pre-clinical deal
December 3, 2014Research and Development, Sales and Marketing DiaPep277, Evotec, Sanofi, oncology, priftin, toulouse
Evotec and Sanofi have entered negotiations for a major multi-component strategic alliance worth around €250 million over the next five …
Packaging machinery specialist, Sepha Ltd, Wins National Award for Excellence in Innovation
December 3, 2014The Northern Ireland-based packaging machinery manufacturer, Sepha Ltd. has won the award for Excellence in Innovation from the UK Chamber …
NICE recommends test to reduce antibiotic use
December 3, 2014Sales and Marketing Antibiotics, GPs, NICE, UK, doctors, icl, pneumonia
NICE guidelines say GPs should use point of care blood tests to assess which patients to prescribe antibiotics for bacterial …
Novartis flu vaccine cleared following safety probe
December 3, 2014Sales and Marketing GSK, Novartis, Vaccine, flu, fluad
The Italian drugs safety agency has cleared the Novartis influenza vaccine Fluad, after an investigation found the vaccine was not …
Hunt sets out plans for expanded NHS budget
December 3, 2014Sales and Marketing Budget, Hunt, NHS, UK, election, health, king's fund
Health secretary Jeremy Hunt has laid out his plans for the future of the NHS in a speech to parliament, …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
